Evidence map›Paper›PMID 17420278›Full record

ArticleMolecular and cellular biology2007

DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2.

A Sobeck, S Stone, M E Hoatlin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. The Fanconi Anemia Pathway in Cancer.Annual review of cancer biology · 2019
    Article
  4. The Plant cell · 2018
    Article
  5. Article
  6. Article
  7. FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A SobeckBiochemistry and Molecular Biology and Molecular and Medical Genetics, Oregon Health and Science University, Medical Research Building, Portland, OR 97239, USA.
S Stone
M E Hoatlin
Oregon Health & Science University · US

Funding

Functional Analysis of the Fanconi PathwayR01CA112775 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HOATLIN, MAUREEN E · 2005 to 2009
$1.4M
NCI NIH HHS CA112775NCI NIH HHS R01 CA112775
6 · The paper itself

Abstract

The Fanconi anemia (FA) pathway proteins are thought to be involved in the repair of irregular DNA structures including those encountered by the moving replication fork. However, the nature of the DNA structures that recruit and activate the FA proteins is not known. Because FA proteins function within an extended network of proteins, some of which are still unknown, we recently established cell-free assays in Xenopus laevis egg extracts to deconstruct the FA pathway in a fully replication-competent context. Here we show that the central FA pathway protein, xFANCD2, is monoubiquitinated (xFANCD2-L) rapidly in the presence of linear and branched double-stranded DNA (dsDNA) structures but not single-stranded or Y-shaped DNA. xFANCD2-L associates with dsDNA structures in an FA core complex-dependent manner but independently of xATRIP, the regulatory subunit of xATR. Formation of xFANCD2-L is also triggered in response to circular dsDNA, suggesting that dsDNA ends are not required to trigger monoubiquitination of FANCD2. The induction of xFANCD2-L in response to circular dsDNA is replication and checkpoint independent. Our results provide new evidence that the FA pathway discriminates among DNA structures and demonstrate that triggering the FA pathway can be uncoupled from DNA replication and ATRIP-dependent activation.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell Cycle ProteinsCell-Free SystemDNADNA, CircularDNA, ComplementaryDNA ReplicationFanconi Anemia Complementation Group D2 ProteinFemaleOocytesPlasmidsProtein Serine-Threonine KinasesSubstrate SpecificityTime FactorsAtaxia Telangiectasia Mutated ProteinsATRIP protein, XenopusAtr protein, XenopusCarrier ProteinsCell Cycle ProteinsDNADNA, CircularDNA, ComplementaryFanconi Anemia Complementation Group D2 ProteinProtein Serine-Threonine KinasesUbiquitinXenopus Proteins

Identifiers

PMID17420278
PMCPMC1900049
OpenAlexW2157866186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.